Healthpeak Properties, Inc. $DOC Shares Sold by Amundi

Amundi lowered its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 41.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,215,354 shares of the real estate investment trust's stock after selling 1,569,223 shares during the period. Amundi owned about 0.32% of Healthpeak Properties worth $47,409,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. OneDigital Investment Advisors LLC increased its stake in shares of Healthpeak Properties by 3.3% in the 2nd quarter. OneDigital Investment Advisors LLC now owns 15,376 shares of the real estate investment trust's stock valued at $329,000 after purchasing an additional 493 shares in the last quarter. Clearstead Trust LLC raised its stake in shares of Healthpeak Properties by 66.7% during the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust's stock worth $29,000 after buying an additional 543 shares during the period. CX Institutional lifted its position in shares of Healthpeak Properties by 6.1% during the 2nd quarter. CX Institutional now owns 11,003 shares of the real estate investment trust's stock valued at $235,000 after buying an additional 633 shares in the last quarter. Fiduciary Trust Co lifted its position in shares of Healthpeak Properties by 4.9% during the 3rd quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust's stock valued at $264,000 after buying an additional 644 shares in the last quarter. Finally, Quadrant Capital Group LLC grew its stake in Healthpeak Properties by 1.9% in the 3rd quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust's stock valued at $721,000 after acquiring an additional 718 shares during the period. 93.57% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Robert W. Baird boosted their price target on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a report on Thursday, August 13th. Raymond James Financial started coverage on shares of Healthpeak Properties in a research report on Wednesday, June 17th. They issued a "market perform" rating on the stock. Wells Fargo & Company boosted their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock an "equal weight" rating in a research note on Wednesday, July 15th. Royal Bank Of Canada upped their price target on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a research report on Monday, August 10th. Finally, Cantor Fitzgerald raised their price target on shares of Healthpeak Properties from $20.00 to $23.00 and gave the company a "neutral" rating in a research note on Thursday, August 6th. Four equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $21.72.

Healthpeak Properties Stock Down 0.1%

Shares of DOC opened at $20.37 on Friday. Healthpeak Properties, Inc. has a 52-week low of $15.70 and a 52-week high of $22.95. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06. The stock has a fifty day simple moving average of $21.45 and a two-hundred day simple moving average of $19.44. The company has a market capitalization of $14.05 billion, a PE ratio of 58.20, a price-to-earnings-growth ratio of 2.51 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm had revenue of $771.58 million during the quarter, compared to analyst estimates of $725.64 million. During the same quarter in the prior year, the firm posted $0.46 earnings per share. Healthpeak Properties's quarterly revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, equities analysts forecast that Healthpeak Properties, Inc. will post 1.77 EPS for the current year.

Healthpeak Properties Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be given a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 6.0%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties's payout ratio is presently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc NYSE: DOC is a real estate investment trust that owns, develops, leases and manages healthcare-related properties in the United States. The company focuses primarily on outpatient medical buildings, which are leased to healthcare providers, physician groups and other medical users.

Healthpeak's portfolio also includes life science and senior housing properties, although its business has increasingly centered on outpatient medical real estate. Its properties are generally located in established healthcare markets and are designed to support services such as physician offices, specialty care, diagnostics and ambulatory treatment.

The company was formerly known as HCP, Inc and adopted the Healthpeak Properties name in 2019.

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.